Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

Some key published and presented research findings include: Adoptive T cell receptor (TCR ... a second CAR molecule improved tumor specificity and enhanced NK cell activity Adding CD28 costimulation ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Bharti says it isn’t clear what exactly caused the vision improvements. It’s possible that the transplanted cells themselves ...

AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the ...

Most research on plant stem cells focuses on the tips of roots and shoots, where growth occurs in height. But Ten Tusscher explains that thickness growth is just as essential. "Plants can't grow ...